Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists), PI3K family inhibitors(Phosphatidylinositol 3-kinase family inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioma | Preclinical | US | - |